What is a UroLume stent?

The UroLume urethral stent (American Medical Systems) was introduced to the market in 1988 for management of male urethral stricture and benign prostatic hyperplasia.

What is a permanent urethral stent?

Ureteral stents are small tubes inserted into the ureter to treat or prevent a blockage that prevents the flow of urine from the kidney to the bladder. The most common reason for ureteral stents is the treatment of kidney stones.

Can a stent be used for urethral stricture?

Memotherm urethral stent is a minimal invasive surgical procedure which can be safely and effectively used in patients with recurrent urethral stricture.

How is UroLift done?

An enlarged prostate compresses on the urethra, making it difficult for urine to flow. The UroLift Device is placed through the obstructed urethra to access the enlarged prostate. The device compresses the tissue and delivers tiny implants to lift and hold prostate tissue out of the way, thus opening the urethra.

Will a stent stretch the ureter?

The stent gently stretches the ureter allowing safe passage of the scope at a later date. Although uncommon, complications may occur following ureteroscopy. Potential risks include, but are not limited to the following: Residual Stones within the Kidney or Ureter It is often not possible to remove the stone intact.

How long does the UroLift procedure last?

7. Is the treatment permanent? The UroLift Implant is a permanent implant, and the treatment is intended to be permanent. Durability has been shown to at least 4 years in U.S. clinical data,1 and results will continue to be published as follow-ups continue.

Can a stent damage your ureter?

The use of ureteral stents is associated with some complications (1, 2, 4, 6). The major complication during ureteral stenting includes increased rates of urinary tract infection (2-4).

Are there any lessons learned from urolume stents?

UroLume stents: lessons learned In our referral experience stent migration and recurrent stenosis were noted following UroLume insertion. Placement of a tandem stent was associated with urethral obstruction. In many cases these adverse outcomes may be secondary to improper patient selection.

Can a tandem stent cause urethral obstruction?

Placement of a tandem stent was associated with urethral obstruction. In many cases these adverse outcomes may be secondary to improper patient selection. Therefore, judicious use of the UroLume stent and proper case selection are essential since stent removal is not always straightforward.

When to use urolume endoprosthesis in men?

Purpose: The UroLume (American Medical Systems, Minnetonka, Minnesota) endoprosthesis has been commercially available since 1990 and has been advocated for use in men with urethral stricture disease and detrusor-sphincter dyssynergia due to spinal cord injury.

When do you need a tandem stent for urosepsis?

All patients with detrusor-sphincter dyssynergia required hospitalization for management of urosepsis within 4 to 10 months of stent placement, and all 4 experienced stent migration requiring placement of a tandem stent (3), bladder neck resection (3) or sphincterotomy (1).